- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00734513
Partner-Assisted Emotional Disclosure for GI Cancer
Partner Assisted Emotional Disclosure for GI Cancer
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The diagnosis and treatment of GI cancer is a traumatic and life-altering event. Many patients with GI cancer experience significant emotional distress and disruptions in their social relationships as well as multiple physical symptoms and limitations in physical activities. There is evidence that cancer patients who are able to confide their feelings and concerns about the cancer experience with supportive others, particularly their partners, fare better. patients who are able to discuss cancer openly with their partners report fewer emotional and physical complaints, and higher levels of self-esteem and perceived control. However, there are a number of barriers that often inhibit discussion of cancer-related feelings. The proposed study will examine the effect of a new partner-assisted emotional disclosure (ED) protocol for patients with GI cancer.
In this study, 200 patients diagnosed with GI cancer and their partners will be recruited to participate. The couples will be randomly assigned to one of two conditions: 1) partner-assisted emotional disclosure, or 2) cancer education. Assessment measures will be collected at evaluations conducted before and after treatment and at 8 weeks post treatment. All evaluations will be conducted over the phone. Information will also be collected from the physician and/or the patient's medical record at each of the three evaluations. Audiotapes of the partner-assisted emotional disclosure sessions will be transcribed and 10-minute segments will be randomly selected and analyzed to assess the extent to which patients express emotions and partners verbally reflect the partner's feeling in an empathic manner.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Duke University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- cancer of the GI system (esophagus, stomach, pancreas, liver, or colorectal; Stage II, III or IV), a life-expectancy of at least 6 months, living with a spouse or intimate partner in a committed relationship, English speaking, and an identified medical oncologist.
Exclusion Criteria:
- None other than absence of inclusion criteria specified above
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Partner-assisted Emotional Disclosure
|
Patients and partners in the partner-assisted emotional disclosure condition will attend four weekly face-to-face sessions with a therapist.
The first session will last 75 minutes and will focus on training in skills to facilitate the patient's disclosure.
The subsequent 3 sessions will last 45 minutes each.
In these sessions, the therapist will briefly review the strategies and provide feedback from the previous session and the patient will spend 30 minutes talking about their cancer-related concerns to the partner.
Other Names:
|
Active Comparator: 2
Cancer Education
|
The cancer education protocol consists of four weekly face-to-face sessions for education about living with GI cancer.
The cancer education sessions will be delivered to patients and their partners and use a presentation and discussion format.
Handouts and discussion sessions will center on the following topics: Orientation to Duke Cancer Care and the treatment team; suggestions for communicating with health care providers; resources for health information, psychosocial support, and financial concerns; evaluating health information on the internet; the impact of cancer on different domains of quality of life; and suggestions for maintaining quality of life.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Patient's psychological adjustment
Time Frame: Immediately after treatment and 8 weeks after completion of treatment
|
Immediately after treatment and 8 weeks after completion of treatment
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Patient's physical and functional well-being
Time Frame: Immediately after treatment and 8 weeks after completion of treatment
|
Immediately after treatment and 8 weeks after completion of treatment
|
Communication quality between the patient and partner (i.e.level of disclosure, helpfulness of disclosure, and perceived empathy from the partner, and decreased partner avoidance and criticism).
Time Frame: Immediately after treatment and 8 weeks after completion of treatment
|
Immediately after treatment and 8 weeks after completion of treatment
|
Partners' psychological well-being and caregiver strain
Time Frame: Immediately after treatment and 8 weeks after completion of treatment
|
Immediately after treatment and 8 weeks after completion of treatment
|
Gender and marital satisfaction as moderators of the effects of partner-assisted ED.
Time Frame: Immediately after treatment and 8 weeks after completion of treatment
|
Immediately after treatment and 8 weeks after completion of treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Laura Porter, Ph.D., Duke University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Pro00011905
- 1R01CA10073-01A1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer of the GI System-stages II III and IV
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)TerminatedSalivary Gland Squamous Cell Carcinoma | Stage II Salivary Gland Cancer | Stage II Squamous Cell Carcinoma of the Hypopharynx | Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage II Squamous Cell Carcinoma of the Oropharynx | Stage II Verrucous Carcinoma of the Oral Cavity | Stage... and other conditionsUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedMucositis | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Verrucous Carcinoma... and other conditionsUnited States
-
University of UtahCelgene CorporationTerminatedStages II-III Breast CancerUnited States
-
Wake Forest University Health SciencesTerminatedStage I Adenoid Cystic Carcinoma of the Oral Cavity | Stage I Mucoepidermoid Carcinoma of the Oral Cavity | Stage I Squamous Cell Carcinoma of the Hypopharynx | Stage I Squamous Cell Carcinoma of the Larynx | Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage I Verrucous Carcinoma... and other conditionsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedRecurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma of the Oropharynx | Recurrent Verrucous Carcinoma of the Larynx | Recurrent Verrucous Carcinoma... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IV Renal Cell Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Recurrent Metastatic Squamous Neck Cancer With... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Stage III Renal Cell Cancer | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Stage IV Ovarian Epithelial Cancer | Stage IIIB Breast Cancer | Stage IV Renal Cell Cancer | Recurrent Renal Cell... and other conditionsUnited States
-
Stanford UniversityCompletedStage II Lymphoepithelioma of the Nasopharynx | Stage II Squamous Cell Carcinoma of the Nasopharynx | Stage III Lymphoepithelioma of the Nasopharynx | Stage III Squamous Cell Carcinoma of the Nasopharynx | Stage IV Lymphoepithelioma of the Nasopharynx | Stage IV Squamous Cell Carcinoma of the...United States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage II Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma... and other conditionsUnited States
Clinical Trials on Partner-assisted emotional disclosure
-
Fred Hutchinson Cancer CenterUniversity of WashingtonCompletedCancer | Hematopoietic Stem Cell TransplantationUnited States
-
Sultan Qaboos UniversityNot yet recruitingQuality of Life | Breast Cancer | Psychological | Expressive Writing
-
Wayne State UniversityUniversity of Southern CaliforniaCompleted
-
University Hospital BirminghamUniversity of BirminghamCompletedHealthyUnited Kingdom
-
University of MiamiCenter for Latino Health Research OpportunitiesCompletedPost Traumatic Stress DisorderUnited States
-
Wayne State UniversityThe New School for Social ResearchRecruitingChronic Pain (Back / Neck)United States
-
Boston UniversityNational Institute of Mental Health (NIMH)CompletedPost-Traumatic Stress DisorderUnited States
-
University of WashingtonUniversity of Nairobi; Kenya Ministry of HealthCompleted
-
University of HoustonAmerican Cancer Society, Inc.; Herald Cancer AssociationCompletedBreast Cancer | Breast NeoplasmUnited States
-
UMC UtrechtCompleted